All animal experiments were conducted in accordance with the principles of laboratory animal care provided by the Institutional Animal Care and Usage Committee of Theravance, Inc.
Receptor-binding studies
Cell membrane preparation Radioligand-binding studies were conducted using membranes prepared from cell lines transfected with the respective human recombinant receptor. Membranes prepared from Chinese hamster ovary-K1 (CHO-K1) cells stably transfected with 5-HT2A and 5-HT2C receptors were prepared as described previously (Stam et al., 1994; Bonhaus et al., 1995). Membranes prepared from CHO-K1 cells stably transfected with 5-HT2B receptors were purchased from Euroscreen (Brussels, Belgium). HEK-293 cells stably transfected with the human recombinant 5-HT4(c) receptor splice variant were cultured in Dulbecco's modified Eagles medium (DMEM) supplemented with D-glucose (4500 mg l−1), 10% foetal bovine serum and 100 U of penicillin (100 μg)–streptomycin ml−1 and geneticin (800 μg ml−1) in a 5% CO2, humidified incubator (37°C). At 20–22 h prior to harvest, cells were washed twice and then cultured in serum-free DMEM. Cells were harvested by gentle mechanical agitation and then centrifugation (1200 × g for 5 min). The pellet was resuspended in 50 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulphonic acid N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulphonic acid) (HEPES), pH 7.4, and homogenized with a polytron disrupter (setting 19, 2 × 10 s) on ice. The resultant homogenate was centrifuged (1200 × g for 5 min), the pellet discarded and the supernatant centrifuged (40,000 × g for 20 min). The pellet was washed once by resuspension in 50 mM HEPES (pH 7.4), and centrifugation (40,000 × g for 20 min). The final pellet was resuspended in 50 mM HEPES (pH 7.4) and aliquots stored at −80°C, until required.
Binding assay conditions Human recombinant 5-HT2A, 5-HT2B, 5-HT2C and 5-HT4(c) receptor membrane radioligand-binding assays were conducted as described previously (Grossman et al., 1993; Stam et al., 1994; Bonhaus et al., 1995; Pindon et al., 2002). Briefly, membranes prepared from cells stably transfected with human recombinant 5-HT2A, 5-HT2B, 5-HT2C and 5-HT4(c) receptors were incubated with radiolabelled ligands with a high affinity for the given receptor, that is, [3H]ketanserin, [N-methyl-3H]lysergic acid diethylamide (LSD), [3H]mesulergine and [3H]GR113808, respectively. Nonspecific radioligand binding was defined by ketanserin (1 μM), 5-HT (10 μM), SB 242084 (10 μM) and GR113808 (1 μM), respectively.
Competition-binding studies were conducted with increasing concentrations of unlabelled ligand (10 pM–30 μM) and a fixed concentration of radioligand (in nM): [3H]ketanserin (0.5), [N-methyl-3H]LSD (1.2), [3H]mesulergine (1) and [3H]GR113808 (0.15). For [3H]GR113808, the radioligand concentration was ~6-fold the KD value, but for all others the concentration was at, or close to, the KD. Following an incubation period sufficient to reach equilibrium: 15 min at 37°C, 30 min at 37°C, 30 min at 37°C and 60 min at 22°C, respectively, the membranes were harvested by rapid filtration and bound radioactivity quantitated by liquid scintillation spectroscopy.
Binding data were analysed by nonlinear regression analysis using GraphPad Prism™ software (GraphPad Software, Inc., San Diego, CA, U.S.A.) and a three-parameter model for one-site competition. pKi (negative decadic logarithm of Ki) values for test compounds were calculated from the best-fit IC50 values, and the Kd value of the radioligand, using the Cheng–Prusoff equation (Cheng & Prusoff, 1973): Ki=IC50/(1+[L]/Kd), where [L] is the concentration of the radioligand.
Functional 5-HT2B receptor activity
Rat isolated stomach fundus The rat stomach fundus responds to 5-HT with a 5-HT2B receptor-mediated contraction (Bonhaus et al., 1999). Adult, male Sprague–Dawley rats (200–350 g, Harlan, IN, U.S.A.) were euthanized by CO2 asphyxiation and thoracotamy. The stomach was cut transversely to isolate the fundus, and the contents were removed by cutting along the smaller curvature of the fundus. The tissue was then transferred to a petri dish containing Tyrode's buffer containing (in mM): KCl (2.4), NaH2PO4 (0.4), MgCl2 (1.1), NaCl (136.9), D-glucose (5.6), NaHCO3 (11.9), CaCl2 (1.8), corticosterone (0.03, to prevent 5-HT uptake) and pargyline (0.1, to inhibit monoamine oxidase). The tissue was cut into strips of approximately 20 mm in length and 2 mm in width, and the longitudinal muscle in each strip was then gently removed from the circular muscle and mucosa by lifting it away with fine forceps. Each strip was mounted, under a tension of 1 g, in a tissue bath filled with Tyrode's solution. The solution was aerated with 95% O2/5% CO2 and maintained at 37°C.
Tissues were allowed to equilibrate for approximately 1 h with washing at 0, 30 and 45 min. A cumulative concentration–effect curve to 5-HT (0.0001–1 μM, in half log increments) was then constructed. Upon completion of the 5-HT concentration–effect curve, the tissues were washed every 5 min for the next 30 min and every 10 min for a further 30 min. Tegaserod was then added and allowed to equilibrate with the tissue for 1 h, and a second concentration–effect curve to 5-HT was then constructed.
Changes in tension of the fundus (and the other in vitro tissue preparations used in this study; vide infra) were recorded by means of a force transducer (World Precision Instruments, model Fort 100), amplifier (Astro Med., model S48) and a data acquisition system (Biopac MP100, Acknowledge™ Waveform Acquisition and Analysis software). Agonist responses (% maximum contraction) were normalized to the maximum response of the first 5-HT concentration–effect curve. Data were analysed through iterative curve fitting to a logistic equation using Prism™ (GraphPad, Inc., San Diego, CA, U.S.A.). The equation used was as follows:
where
X is the logarithm of the drug concentration, and
Y is the response (starting from the bottom of the curve and going to the top with a sigmoid shape). For antagonist studies, the concentration ratios (with respect to the 5-HT concentration–effect curves in the absence and presence of antagonist) were calculated, and a p
Kb (calculated at a single antagonist concentration) or p
A2 value determined by Schild regression analysis (
Arunlakshana & Schild, 1959).
Rat stomach pressure Adult male Sprague–Dawley rats (280–390 g, Harlan, IN, U.S.A.), fasted overnight prior to the study, were anaesthetized with isoflurane (3%) in oxygen. The abdomen was shaved and a midline incision made to expose the duodenum. A small incision was made in the duodenum, approximately 2 cm from the pyloric sphincter, and a water-filled balloon (size no. 6, Harvard), connected to a polyethylene catheter (PE50 tubing), was inserted into the stomach fundus via the duodenal incision. The catheter was connected to a pressure transducer and data acquisition system (Biopac MP100, Acknowledge™ Waveform Acquisition and Analysis software) to allow continuous recording of fundus pressure to be made. The incisions in the duodenum and abdomen were closed (4–0 silk suture; Ethicon, Inc., Somerville, NJ, U.S.A.) and a stitch in the skin was used to secure the balloon catheter. The balloon was then filled with 3.0 ml of water from a 10 ml syringe using an infusion pump (0.5 ml min−1, World Precision Instruments, Sarasota, FL, U.S.A. SP230iw). An incision was made in the neck, and the left jugular vein and carotid artery were exposed and catheterized (PE50 tubing). The carotid arterial cannula (pre-filled with heparin (50 U ml−1) in 0.9% saline) was connected via a pressure transducer (Biopac) to the Biopac data acquisition system to enable the measurement of blood pressure.
Rats were allowed at least 30 min to stabilize following surgery. Typically, spontaneous rhythmical changes in balloon pressure commenced during this period, representing contractility of the stomach fundus. The selective 5-HT2B receptor agonists, α-methyl 5-HT (0.03 mg kg−1) and BW 723C86 (0.3 mg kg−1), or their vehicles, were administered via the jugular venous catheter (1 ml kg−1). These doses of α-methyl 5-HT and BW 723C86 were selected, as in initial experiments they were associated with increases in stomach pressure without marked changes in blood pressure. At 15 min after dosing with α-methyl 5-HT (0.03 mg kg−1), tegaserod or its vehicle was administered subcutaneously (1 ml kg−1). The selective 5-HT4 receptor antagonist, piboserod (1 mg kg−1; Sanger et al., 1998), was co-administered with tegaserod to exclude any influence of 5-HT4 receptor activation on stomach pressure. After a further 15 min, rats were dosed with α-methyl 5-HT (0.03 mg kg−1). Responses to α-methyl 5-HT were compared, by measuring the amplitude and area of stomach contractions, and data were expressed for the second α-methyl 5-HT challenge as a percentage of the first (statistical significance at P<0.05 by ANOVA and Dunnett's post hoc test, comparing the tegaserod and vehicle-induced responses). To avoid tachyphylaxis, each rat was challenged only once with BW 723C86, 15 min after subcutaneous co-administration of piboserod (1 mg kg−1) with either tegaserod (1 mg kg−1) or its vehicle, and data were compared by unpaired Student's t-test, with statistical significance set at P<0.05. The effect of the selective 5-HT2B/2C receptor antagonist, SB 206553 (1 mg kg−1; Kennett et al., 1996), on the BW 723C86 responses was also investigated.
Functional 5-HT4 receptor activity
Whole-cell cAMP accumulation studies Whole-cell cAMP accumulation studies were conducted using HEK-293 cells stably transfected with the human recombinant 5-HT4(c) receptor splice variant (Bmax=500–800 fmol mg−1 protein) and the Flashplate Adenylyl Cyclase Activation Assay System (NEN, SMP004B), as described previously (Pindon et al., 2002).
Cell culture Cells were cultured as described above (see Section cell membrane preparation). Cells were grown to 60–80% confluency and, at 20–22 h prior to harvest, washed twice and then cultured in serum-free DMEM. To harvest the cells, the media was aspirated and the cells were incubated for 5 min at room temperature with Versene (Life Technologies, Inc., Grand Island, NY, U.S.A.). The cells were lifted from the flask by gentle mechanical agitation, suspended in pre-warmed (37°C) Dulbecco's phosphate-buffered saline, and then harvested by centrifugation at 1200 × g for 5 min. The supernatant was discarded and the pellet was resuspended in pre-warmed (37°C) ‘stimulation buffer' provided with the Flashplate kit.
Measurement of cAMP formation Briefly, cells were diluted to a concentration of 5 × 105 cells ml−1 in pre-warmed (37°C) ‘stimulation buffer', and preincubated at 37°C for 10 min. Cyclic AMP accumulation assays were performed with increasing concentrations of tegaserod and 5-HT (10 pM–100 μM). Cell suspension (50 μl) was added to each well of the Flashplate for a final assay volume of 100 μl. The cells were incubated, with shaking, at 37°C for 15 min. After the incubation period, a direct radioimmunoassay, using 125I-cAMP, was performed by the addition of 100 μl of ice-cold ‘detection buffer' to each well, according to the manufacturer's instructions. The plates were sealed and incubated at 4°C, overnight. Bound radioactivity was quantified by scintillation proximity spectroscopy using the Topcount (Packard BioScience Co., Meriden, CT, U.S.A.).
The amount of cAMP produced was extrapolated from a cAMP standard curve. Data were analysed by nonlinear regression analysis with the GraphPad Prism Software package (GraphPad Software, Inc., San Diego, CA, U.S.A.) using the three-parameter sigmoidal dose model (slope constrained to unity). Potency data were reported as pEC50 values (negative decadic logarithm of the effective concentration producing 50% of the maximum response; mean±s.d., n>3). To determine the intrinsic activity (IA), relative to 5-HT, the maximum compound-evoked response (minus basal) was expressed as a percentage of the maximum response evoked by 5-HT (minus basal), assayed in parallel on the same plate.
Rat isolated oesophagus The rat precontracted oesophageal tunica muscularis mucosa responds to 5-HT4 receptor activation with relaxation (Briejer et al., 2001). Adult, male Sprague–Dawley rats (250–350 g, Harlan, IN, U.S.A.) were euthanized by CO2 asphyxiation and thoracotamy. The thoracic oesophagus was removed and placed in Tyrode's buffer containing (in μM) indomethacin (3.0; to inhibit prostaglandin synthesis), corticosterone (30.0; to prevent 5-HT uptake) and ketanserin (1.0; to block 5-HT2 receptors). A pair of scissors was inserted between the submucosal layers and the outer striated muscle coat was cut longitudinally, and then gently peeled away leaving the inner tunica muscularis mucosa. Preparations of the tunica muscularis mucosa, each approximately 20 mm in length and 2 mm in width, were mounted longitudinally in 10 ml tissue baths filled with Tyrode's solution, which were aerated continuously with 95% O2/5% CO2, and maintained at 37°C.
A tension of 0.5 g was applied to each tissue. During the next 60 min, tissues were washed at 15 min intervals and tension re-applied to 0.5 g as necessary. Carbachol (3 μM; determined to be a submaximal concentration in initial experiments) was then added to the tissue baths to contract the oesophagus. When the contraction had reached a maximum and the tone had stabilized, a cumulative concentration–effect curve to 5-HT (0.001–10 μM in half-log increments) was constructed. Upon completion of the concentration–effect curve, the tissues were washed four times at 5 min intervals and then three more times every 15 min. Carbachol (3 μM) was then added to the tissue baths, and, when the contraction had stabilized, concentration–effect curves to tegaserod or 5-HT (each at 0.001–10 μM), were constructed. Responses (i.e. relaxations of carbachol-induced tone) were allowed to reach a maximum before addition of the next, ascending concentration. The mean potency (pEC50) and IA (as a percentage of the 5-HT maximum response observed in the first 5-HT concentration–effect curve) were derived through iterative curve fitting (Prism™; GraphPad, Inc.).
Guinea-pig isolated colon Adult, male Dunkin Hartley guinea-pigs (200–300 g, Harlan, IN, U.S.A.) were euthanized by CO2 asphyxiation and thoracotamy. The colon was removed, and placed in Krebs-Henseleit physiological buffer, containing (in mM): KCl (4.7), KH2PO4 (1.2), MgSO4 anhydrous (1.2), NaCl (118.1), D-glucose (11.1), NaHCO3 (25.0), CaCl2 (2.6), ondansetron (0.003; to block 5-HT3 receptors), methysergide (0.001; to block 5-HT1 and 5-HT2 receptors) and indomethacin (0.001; to inhibit prostaglandin synthesis). The colon was cut into 5 cm lengths, the contents gently removed and each segment then placed on a 10 ml pipette. An incision was made along the length of the colon with a scalpel blade, and the longitudinal muscle was then peeled off carefully using the tip of a thumb. Each longitudinal muscle strip was then mounted, under a tension of 1 g, in a 10 ml tissue bath filled with Krebs-Henseleit buffer. The bathing solution was aerated continuously with 95% O2/5% CO2, and maintained at 37°C.
During the next 45 min, tissues were washed three times (at 0, 15 and 30 min after mounting) and tension re-applied to 1 g as necessary. The tissues were then challenged with 5-HT at a concentration (0.3 μM) previously established to evoke a maximal contractile response. Once the contraction had reached its maximum, tissues were washed four times every 2 min and once more 10 min later. An additional priming challenge of 5-HT (0.3 μM) was made 15 min later. Following further washing prior to, and after a third 5-HT (0.3 μM) challenge, a cumulative concentration–effect curve to 5-HT (0.0001–3 μM) or tegaserod (0.0001–10 μM) was constructed. Responses were allowed to reach a maximum before addition of the next, ascending concentration. Contractile responses were normalized to the primed 5-HT (0.3 μM) response in each tissue. Data were analysed through iterative curve fitting to a logistic equation using Prism™ (GraphPad, Inc.). The mean potency (pEC50) and IA (as a percentage of the 5-HT maximum response) were derived.
Colonic transit in conscious guinea-pigs Adult, male Duncan Hartley guinea-pigs (220–580 g, Harlan, IN, U.S.A.) were acclimated to the holding room (temperature controlled at 21±1°C and 12 : 12 h light–dark cycle commencing at 07:00 h) for at least 1 week following arrival.
Guinea-pigs were anaesthetized with isoflurane (2–3%) in an induction chamber. Maintenance of anaesthesia was achieved with isoflurane (2–3%) administered via a nose cone. The mid-scapular area and abdomen were shaved and cleansed with betadine and 70% isopropanol. The proximal colon was exposed, and a small incision made (approximately 2 cm from the cecum). A cannula consisting of micro-renathane (MRE-040) tubing with a 2 cm silicone rubber tip (0.047″ OD × 0.025″ ID) was introduced and advanced approximately 2 cm towards the aboral end. A purse-string suture (6-0 silk) was used to fix the cannula in the colon and an antibiotic (Baytril®; 2.27%) was then applied to the incision. The muscle layer was closed with a 4-0 Vicryl® suture (Ethicon, Inc.). The cannula was then secured to the nearby musculature with a 6-0 silk suture (Ethicon, Inc.) and tunnelled subcutaneously under the skin and exteriorized at the mid-scapular region. The cannula was sealed with a stainless steel pin and secured to the back of the neck with wound clips. The incisions in the peritoneum and abdomen were cleansed of blood and closed with a 3-0 Ethilon® suture (Ethicon, Inc.). Buprenex® (0.03 mg kg−1) was administered subcutaneously immediately after surgery.
At least 5 days post-surgery, guinea-pigs were assigned randomly to a study group. At 5 min after subcutaneous administration of tegaserod (0.03–3 mg kg−1) or vehicle, guinea-pigs were gently restrained and a nonabsorbable marker (0.2 ml) was infused into the proximal colon via the implanted cannula. The marker consisted of 6 g of carmine red dye per 15 ml of carboxymethyl cellulose (0.5%). The study personnel were blinded to the treatment that each animal received.
Commencing at 60 min after the infusion of the dye, animal cages were inspected visually for the presence of excreted red faecal pellets. This was repeated at 30 min intervals until each guinea-pig had excreted pellets containing the red marker, or until 10 h had lapsed from the time of the marker injection. In the case that an animal failed to produce red faecal pellets within 10 h, the animal was left overnight and inspected the following morning. If excretion of dye occurred overnight, a value of 10 h was assigned. Any guinea-pig that failed to produce red faecal pellets was removed from the study, and a post-mortem exploration of the abdominal cavity was performed. In these rare instances (<1% of animals), it was generally noted that the colonic catheter had been dislodged from the colon.
The whole colonic transit was defined as the time that lapsed between marker injection and the appearance of dye in the faeces. Data for each treatment group were averaged and expressed as the mean (±s.d.) transit time. Differences between treatment groups were then determined using one-way analysis of variance (ANOVA) with a Dunnett's post hoc test (P<0.05 considered to be statistically significant).
Materials
5-HT, indomethacin, ketanserin, pargyline, methysergide, SB 242084, carmine red dye and corticosterone were purchased from Sigma-Aldrich, St Louis, MO, U.S.A. Tegaserod and ondansetron were purchased from Apin Chemicals, Abingdon, Oxfordshire, U.K. and Sequoia Research Products, Oxford, Oxfordshire, U.K. respectively, while
α-methyl 5-HT, SB 206553, BW 723C86 and GR113808 were purchased from Tocris Cookson, Ellisville, MO, U.S.A. Buprenex and Baytril were purchased from Reckitt & Colman Products, Richmond, VA, U.S.A. and Bayer, Shawnee Mission, KS, U.S.A., respectively. [
3H]ketanserin and [
N-methyl-
3H]LSD were purchased from Perkin-Elmer, Boston, MA, U.S.A., while [
3H]mesulergine and [
3H]GR113808 were purchased from Amersham Biosciences, Newark, NJ, U.S.A. Piboserod was synthesized, as described by
Gaster et al. (1995).
For radioligand-binding and cAMP accumulation studies, tegaserod and 5-HT were prepared at 10 mM in dimethyl sulphoxide (DMSO), diluted to 400 μM with 50 mM HEPES (pH 7.4) at 25°C, containing 0.1% bovine serum albumin (BSA), and then serially diluted (1 : 5) in the same buffer. For rat oesophagus and stomach, and guinea-pig colon, in vitro experiments, tegaserod was prepared at 10 mM in DMSO and then serially diluted in water, while 5-HT was dissolved in water. For in vivo experiments, α-methyl 5-HT, piboserod and SB 206553 were dissolved in 0.9% saline or 5% dextrose in water (D5W), while tegaserod was prepared in 10% sulphobutyl ether-beta cyclodextrin (10% SBE/CD). BW 723C86 was formulated in DMSO (1% by volume) in D5W. In vivo doses were expressed with respect to the free base weights of each compound.